ERBB2 and breast carcinoma: Polzer et al. tested HER2 amplification (by qPCR) and PIK3CA mutations (by Sanger sequencing) in exon 9 and 20 in CTCs isolated from breast cancer patients (stage I-IV) with CellSearch-enrichment and DEPArray single cells recovery.